Thoracentesis in Acute Heart Failure: Insights from the TAP-IT Randomized Controlled Trial
Highlight
The TAP-IT trial evaluated the role of routine thoracentesis added to standard medical therapy in acute heart failure patients with moderate pleural effusion. No significant benefit was demonstrated in days alive out of hospital, mortality, or hospital stay length. Procedural complications were rare, supporting safety of thoracentesis but questioning its routine use.
Study Background and Disease Burden
MedXY registered readers
Sign in free to continue reading
Create or use your MedXY account to unlock the complete article.
This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.